Clinical Trial

Extracellular Vesicles for Rejection Monitoring in Cardiac Transplantation

Study acronym: ExoRejeCT
Recruiting
View on ClinicalTrials.gov →
Summary
This study will analyze extracellular vesicle (EV)-derived protein profiles in heart transplantated patients during the first 15 months post-transplantation to investigate, if there are distinct EV-derived proteins or protein patterns that allow early and reliable diagnosis of acute cardiac allograft rejection. Additionally, it will explore temporal changes in the EV-derived protein profile during the early postoperative period irrespective of acute allograft rejection, and will investigate, if there are correlations between EV protein markers and imaging findings.
Protocol Amendment History 1 change
minor Trial arms changed: 0 -> 1 2026-07-02
Trial Details
NCT Number NCT07673536
Lead Sponsor Laurenz Kopp Fernandes
Conditions Rejection Heart Transplant
Enrollment 30 participants
Start Date 2026-06-18
Primary Completion 2028-09-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-01